JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M709677200 on December 6, 2007

J. Biol. Chem., Vol. 283, Issue 6, 3097-3108, February 8, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/6/3097    most recent
M709677200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Raven, J. F.
Right arrow Articles by Koromilas, A. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raven, J. F.
Right arrow Articles by Koromilas, A. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PKR and PKR-like Endoplasmic Reticulum Kinase Induce the Proteasome-dependent Degradation of Cyclin D1 via a Mechanism Requiring Eukaryotic Initiation Factor 2{alpha} Phosphorylation*Formula

Jennifer F. Raven{ddagger}§1, Dionissios Baltzis{ddagger}§2, Shuo Wang§3, Zineb Mounir{ddagger}§34, Andreas I. Papadakis{ddagger}§5, Hong Qing Gao§, and Antonis E. Koromilas{ddagger}§6

From the {ddagger}Department of Oncology, Faculty of Medicine, McGill University, Montreal, Quebec H2W 1S6, Canada and §Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada

Cyclin D1 plays a critical role in controlling the G1/S transition via the regulation of cyclin-dependent kinase activity. Several studies have indicated that cyclin D1 translation is decreased upon activation of the eukaryotic initiation factor 2{alpha} (eIF2{alpha}) kinases. We examined the effect of activation of the eIF2{alpha} kinases PKR and PKR-like endoplasmic reticulum kinase (PERK) on cyclin D1 protein levels and translation and determined that cyclin D1 protein levels decrease upon the induction of PKR and PERK catalytic activity but that this decrease is not due to translation. Inhibition of the 26 S proteasome with MG132 rescued cyclin D1 protein levels, indicating that rather than inhibiting translation, PKR and PERK act to increase cyclin D1 degradation. Interestingly, this effect still requires eIF2{alpha} phosphorylation at serine 51, as cyclin D1 remains unaffected in cells containing a non-phosphorylatable form of the protein. This proteasome-dependent degradation of cyclin D1 requires an intact ubiquitination pathway, although the ubiquitination of cyclin D1 is not itself affected. Furthermore, this degradation is independent of phosphorylation of cyclin D1 at threonine 286, which is mediated by the glycogen synthase kinase 3β and mitogen-activated protein kinase pathways as described in previous studies. Our study reveals a novel functional cross-talk between eIF2{alpha} phosphorylation and the proteasomal degradation of cyclin D1 and that this degradation is dependent upon eIF2{alpha} phosphorylation during short, but not prolonged, periods of stress.


Received for publication, November 27, 2007

* This work was supported in part by grants from the National Cancer Institute of Canada and the Canadian Institute of Health Research (to A. E. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.

1 Recipient of a United States Army Predoctoral Traineeship Award.

2 Recipient of the Terry Fox Research Studentship from the National Cancer Institute of Canada.

3 These authors contributed equally to this work.

4 Recipient of a Canadian Institute of Health Research Canada Graduate Student Award.

5 Recipient of the Canderel Studentship Award from the McGill Cancer Centre.

6 To whom correspondence should be addressed: Lady Davis Institute for Medical Research, Rm. 508, Sir Mortimer B. Davis Jewish General Hospital, 3999 Ch. de la Côte-Ste.-Catherine, Montréal, Québec H3T 1E2, Canada. Tel.: 514-340-8222 (ext. 3697); Fax: 514-340-7576; E-mail: antonis.koromilas{at}mcgill.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.